On June 4, 2024, the New York Stock Exchange (NYSE) hosted a grand event to unveil the 2024 Fortune 500 list, marking its 70th anniversary. Kevin Xu, Chairman of MEBO Group, was a distinguished guest at this prestigious celebration.

This year's event not only celebrated the iconic list but also introduced "Fortune Insights," a revolutionary AI analysis tool developed with Accenture. This tool provides in-depth analysis and reports based on Fortune 500 data, enabling businesses to make well-informed decisions. Kevin Xu actively engaged with global business leaders and industry experts, discussing key trends in the global economy and industry advancements.

Walmart, Amazon, and Apple secured the top three positions on the 2024 Fortune 500 list. Since 1955, this list has served as a benchmark for the largest publicly traded companies in the United States, reflecting their growth trajectories and the dynamic global economy.

Kevin Xu's involvement underscores MEBO Group's strong relationship with Fortune and its commitment to global initiatives. The Fortune CEO Initiative's 2019 Annual Report highlighted MEBO's significant contributions, including the "Belt and Road" global regenerative medicine training program. This program offers international training for medical and nursing professionals in regenerative medical technology. Since 2017, Kevin Xu has been a regular participant in Fortune events, such as the Fortune Global Forum, the Fortune Global Sustainability Forum, and the annual Fortune CEO Initiative meetings. His frequent interviews with Fortune magazine further demonstrate his influence and MEBO Group's global impact.

Under Kevin Xu's leadership, MEBO Group continues to reach new heights, driving innovation and fostering international collaboration. The company's ongoing projects and global initiatives reflect its dedication to advancing medical technology and improving healthcare worldwide.

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.

About Fortune

Fortune is a global multi-platform media company built on a legacy of trusted, award-winning reporting and information for those who want to make business better. Independently owned, Fortune tells the stories of the world's biggest companies and their leaders as well as a new generation of innovators who are moving business forward. Digitally and in print, Fortune measures corporate performance through rigorous benchmarks, and holds companies accountable, in regions around the world. Its iconic rankings include Fortune 500, Fortune Global 500, Most Powerful Women, and World's Most Admired Companies. Fortune builds world-class communities by convening industry thought leaders for exclusive summits and conferences, including the Fortune Global Forum and Brainstorm Tech